DE602004022515D1 - Fenofibrate tablett und verfahren zur herstellung - Google Patents
Fenofibrate tablett und verfahren zur herstellungInfo
- Publication number
- DE602004022515D1 DE602004022515D1 DE602004022515T DE602004022515T DE602004022515D1 DE 602004022515 D1 DE602004022515 D1 DE 602004022515D1 DE 602004022515 T DE602004022515 T DE 602004022515T DE 602004022515 T DE602004022515 T DE 602004022515T DE 602004022515 D1 DE602004022515 D1 DE 602004022515D1
- Authority
- DE
- Germany
- Prior art keywords
- preparing
- active ingredient
- fenofibrate tablet
- fenofibrate
- tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 3
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002297 fenofibrate Drugs 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 3
- 238000007906 compression Methods 0.000 abstract 1
- 230000006835 compression Effects 0.000 abstract 1
- 238000005469 granulation Methods 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0302520A FR2851734B1 (fr) | 2003-02-28 | 2003-02-28 | Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede |
PCT/FR2004/050090 WO2004078108A2 (fr) | 2003-02-28 | 2004-02-27 | Comprime de fenofibrate et procede de fabrication |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004022515D1 true DE602004022515D1 (de) | 2009-09-24 |
Family
ID=32843093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004022515T Expired - Lifetime DE602004022515D1 (de) | 2003-02-28 | 2004-02-27 | Fenofibrate tablett und verfahren zur herstellung |
Country Status (20)
Country | Link |
---|---|
US (1) | US20060177499A1 (de) |
EP (1) | EP1601346B1 (de) |
JP (1) | JP2006520770A (de) |
CN (1) | CN100479808C (de) |
AT (1) | ATE439125T1 (de) |
AU (1) | AU2004216869B2 (de) |
BR (1) | BRPI0407850A (de) |
CA (1) | CA2517429C (de) |
DE (1) | DE602004022515D1 (de) |
FR (1) | FR2851734B1 (de) |
IL (1) | IL170507A (de) |
MA (1) | MA27662A1 (de) |
MX (1) | MXPA05009113A (de) |
NO (1) | NO20054417L (de) |
NZ (1) | NZ542039A (de) |
PL (1) | PL378106A1 (de) |
RU (1) | RU2362547C2 (de) |
TN (1) | TNSN05203A1 (de) |
WO (1) | WO2004078108A2 (de) |
ZA (1) | ZA200506992B (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006273849A (ja) * | 2005-03-02 | 2006-10-12 | Aska Pharmaceutical Co Ltd | フェノフィブラート含有組成物 |
KR101324898B1 (ko) * | 2006-03-31 | 2013-11-04 | 루비콘 리서치 피브이티. 엘티디. | 구강 붕해 정제 |
CA2638240C (en) * | 2008-08-29 | 2010-02-02 | Alexander Macgregor | Method of treating dysglycemia and glucose excursions |
JP5452051B2 (ja) * | 2009-03-27 | 2014-03-26 | 杏林製薬株式会社 | イミダフェナシン含有口腔内崩壊錠 |
CN102675748A (zh) * | 2012-05-22 | 2012-09-19 | 苏州新区华士达工程塑胶有限公司 | 一种耐候聚丙烯的配方 |
US10966934B2 (en) * | 2017-02-20 | 2021-04-06 | Dsm Ip Assets B.V. | Process for producing coated particles |
KR102271734B1 (ko) * | 2020-10-21 | 2021-07-01 | 한국프라임제약주식회사 | 건식과립공정용 멀티비타민 약제학적 조성물 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2627696B1 (fr) * | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | Nouvelle forme galenique du fenofibrate |
FR2730231B1 (fr) * | 1995-02-02 | 1997-04-04 | Fournier Sca Lab | Association de fenofibrate et de vitamine e, utilisation en therapeutique |
FR2758461A1 (fr) * | 1997-01-17 | 1998-07-24 | Pharma Pass | Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation |
FR2758459B1 (fr) * | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
FR2772615B1 (fr) * | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
FR2774591B1 (fr) * | 1998-02-12 | 2000-05-05 | Lipha | Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie |
FR2781793B1 (fr) * | 1998-08-03 | 2001-07-20 | Prographarm Lab | Procede de fabrication de granules de gabapentine enrobes |
US6180138B1 (en) * | 1999-01-29 | 2001-01-30 | Abbott Laboratories | Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption |
CA2407027C (en) * | 2000-04-20 | 2011-02-15 | Rtp Pharma Inc. | Improved water-insoluble drug particle process |
FR2819720B1 (fr) * | 2001-01-22 | 2004-03-12 | Fournier Lab Sa | Nouveaux comprimes de fenofibrate |
CN1273112C (zh) * | 2001-02-22 | 2006-09-06 | 斯凯伊药品加拿大公司 | 具有减少进食-禁食作用的贝特-它汀组合 |
JPWO2002069957A1 (ja) * | 2001-03-01 | 2004-07-02 | グレラン製薬株式会社 | フェノフィブラート含有組成物 |
-
2003
- 2003-02-28 FR FR0302520A patent/FR2851734B1/fr not_active Expired - Fee Related
-
2004
- 2004-02-27 WO PCT/FR2004/050090 patent/WO2004078108A2/fr not_active Application Discontinuation
- 2004-02-27 PL PL378106A patent/PL378106A1/pl not_active Application Discontinuation
- 2004-02-27 DE DE602004022515T patent/DE602004022515D1/de not_active Expired - Lifetime
- 2004-02-27 EP EP04715360A patent/EP1601346B1/de not_active Expired - Lifetime
- 2004-02-27 US US10/546,999 patent/US20060177499A1/en not_active Abandoned
- 2004-02-27 BR BRPI0407850-0A patent/BRPI0407850A/pt not_active IP Right Cessation
- 2004-02-27 NZ NZ542039A patent/NZ542039A/en unknown
- 2004-02-27 CA CA2517429A patent/CA2517429C/fr not_active Expired - Fee Related
- 2004-02-27 AU AU2004216869A patent/AU2004216869B2/en not_active Ceased
- 2004-02-27 MX MXPA05009113A patent/MXPA05009113A/es active IP Right Grant
- 2004-02-27 JP JP2006505844A patent/JP2006520770A/ja active Pending
- 2004-02-27 CN CNB2004800113413A patent/CN100479808C/zh not_active Expired - Fee Related
- 2004-02-27 RU RU2005130155/15A patent/RU2362547C2/ru not_active IP Right Cessation
- 2004-02-27 AT AT04715360T patent/ATE439125T1/de not_active IP Right Cessation
-
2005
- 2005-08-25 IL IL170507A patent/IL170507A/en not_active IP Right Cessation
- 2005-08-26 MA MA28458A patent/MA27662A1/fr unknown
- 2005-08-26 TN TNP2005000203A patent/TNSN05203A1/fr unknown
- 2005-08-31 ZA ZA200506992A patent/ZA200506992B/xx unknown
- 2005-09-23 NO NO20054417A patent/NO20054417L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20054417L (no) | 2005-09-23 |
WO2004078108A3 (fr) | 2004-12-09 |
AU2004216869B2 (en) | 2009-05-14 |
IL170507A (en) | 2011-11-30 |
JP2006520770A (ja) | 2006-09-14 |
BRPI0407850A (pt) | 2006-03-14 |
ATE439125T1 (de) | 2009-08-15 |
WO2004078108A2 (fr) | 2004-09-16 |
TNSN05203A1 (fr) | 2007-06-11 |
FR2851734A1 (fr) | 2004-09-03 |
FR2851734B1 (fr) | 2006-06-09 |
CN1780606A (zh) | 2006-05-31 |
ZA200506992B (en) | 2007-04-25 |
CA2517429A1 (fr) | 2004-09-16 |
RU2005130155A (ru) | 2006-06-10 |
MXPA05009113A (es) | 2006-05-31 |
MA27662A1 (fr) | 2005-12-01 |
US20060177499A1 (en) | 2006-08-10 |
PL378106A1 (pl) | 2006-03-06 |
EP1601346A2 (de) | 2005-12-07 |
AU2004216869A1 (en) | 2004-09-16 |
NZ542039A (en) | 2008-08-29 |
CN100479808C (zh) | 2009-04-22 |
CA2517429C (fr) | 2012-04-17 |
EP1601346B1 (de) | 2009-08-12 |
RU2362547C2 (ru) | 2009-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2402063B (en) | Pharmaceutical composition for controlled release of active substances and the manufacturing method thereof | |
DE602005010788D1 (de) | Pharmazeutische Zusammensetzungen zur sicheren Verabreichung von bei der Behandlung von Drogenabhängigkeit verwendeten Arzneimitteln | |
EA200801926A1 (ru) | Таблетки парацетамола с быстрым высвобождением | |
NO20062504L (no) | Sammensetninger og doseringsformer for forbedret absorpsjon | |
HRP20090194T1 (en) | Dry granulated composition comprising emtricitabine and tenofovir df | |
DK1957110T3 (da) | Fremgangsmåde til fremstilling af tygbare doseringsformer til lægemiddeladministration og produkter dermed | |
NO340679B1 (no) | Pyridazinonderivativer, farmasøytiske preparater omfattende slike og slike forbindelser og preparater for anvendelse i terapeutisk aktive substanser til behandling og forebygging av sykdommer | |
ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
DK1654253T3 (da) | Substituerede 3-pyrrolidinindolderivater | |
NO20064934L (no) | Fremgangsmate for fremstilling av et fast, farmasoytisk preparat | |
ATE354362T1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff | |
DE60131760D1 (de) | Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform | |
NO20054417L (no) | Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter | |
BG108516A (en) | Pharmaceutical formulation | |
ZA200700397B (en) | Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same | |
BRPI0518790A2 (pt) | formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete | |
SK500402007A3 (sk) | Spôsob recyklácie odpadu z priemyselných výrob obsahujúceho zmes organických rozpúšťadiel a zariadenie na vykonávanie tohto spôsobu | |
ATE262893T1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
AR048672A1 (es) | Tabletas de desintegracion que comprenden licarbazepina | |
EA200801614A1 (ru) | Фармацевтическая композиция, содержащая монтелукаст | |
IS7266A (is) | Lyfjaform sem innihalda sýru-óþolin virk efni og aðferðir til tilreiðslu þeirra | |
IS7424A (is) | Oxasólídínónafleiður, aðferðir til að framleiða þær og lyfjablöndur sem innihalda þær | |
NO20076120L (no) | Stabile nanopartikkelformuleringer | |
IS7383A (is) | Skammtaform með stýrða lyflosun til inngjafar | |
TR200301553A1 (tr) | İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |